基于蛋白质组的结核病宿主特定生物标志物:结核病诊断的未来
Divya Pandey1, Dipanjana Ghosh2
1Department of Pharmaceutical Sciences, School of Health Sciences and Technology, UPES, Dehradun 248007, Uttarakhand, India.
Journal of proteomics
|June 28, 2024
概括
识别宿主特异性蛋白质生物标志物对于早期结核病 (TB) 检测至关重要. 蛋白质组学研究揭示了结核病患者的免疫和代谢蛋白质变化,提供了新的诊断和治疗途径.
科学领域:
- 蛋白质组学是指蛋白质组学.
- 传染性疾病 传染性疾病
- 生物标志物发现发现
背景情况:
- 结核病 (TB) 是一个重要的全球卫生问题,需要改进诊断.
- 目前的结核病诊断方法在灵敏度,有效性和成本上都有局限性.
- 快速,敏感和负担得起的结核病诊断对于疾病控制至关重要.
研究的目的:
- 对结核病中宿主特定生物标志物的蛋白质组学研究进行审查.
- 从各种生物样本 (血清,唾液,唾液,尿液) 中识别潜在的生物标志物.
- 为了探索宿主特异性蛋白质放松对Mycobacterium结核病 (Mtb) 感染的调节.
主要方法:
- 蛋白质组学研究的综合文献数据挖掘.
- 对结核病患者和伴随疾病患者宿主特异性蛋白质表达的分析.
- 专注于参与免疫,新陈代谢,炎症和组织重塑的蛋白质.
主要成果:
- 与免疫,新陈代谢和炎症相关的宿主特异性蛋白质在结核病中受到放松.
- 在多种样本类型中,ORM蛋白在活跃的结核病患者中被上调.
- 曼诺酶受体C型2 (MRC2) 是血清蛋白质学中一个上调治疗反应生物标志物.
结论:
- 蛋白质组学为结核病诊断和治疗监测提供了有前途的宿主特定生物标志物.
- 研究ORM和MRC2等候选蛋白质可以导致新的药物标和个性化疗法.
- 需要进一步的机制研究才能充分理解这些生物标志物的诊断和治疗潜力.
更多相关视频
相关概念视频
01:26Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
01:31Pulmonary Tuberculosis III
321
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
321
01:28Pulmonary Tuberculosis V
177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
01:28Pulmonary Tuberculosis II
217
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
217